Review: taking Coumadin and Nasonex together


Summary

Drug interactions are reported among people who take Coumadin and Nasonex together. This review analyzes the effectiveness and drug interactions between Coumadin and Nasonex. It is created by eHealthMe based on reports of 293 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Coumadin and Nasonex >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Coumadin

Coumadin has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Coumadin 73,237 users)

Nasonex

Nasonex has active ingredients of mometasone furoate.

On Jul, 28, 2016

293 people who take Coumadin, Nasonex are studied.


Number of reports submitted per year:

Coumadin and Nasonex drug interactions.

Drug effectiveness over time:

Coumadin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (2 of 2 people)
  • 5 - 10 years: 100.0% - (6 of 6 people)
  • 10+ years: 100.0% - (4 of 4 people)
  • not specified: 0.0% - (0 of 0 people)
Nasonex:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 4 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (3 of 3 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Coumadin:
  • female: 100.0% - (8 of 8 people)
  • male: 100.0% - (4 of 4 people)
Nasonex:
  • female: 60.0% - (3 of 5 people)
  • male: 25.0% - (1 of 4 people)

Drug effectiveness by age:

Coumadin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 100.0% - (3 of 3 people)
  • 50-59: 100.0% - (2 of 2 people)
  • 60+: 100.0% - (7 of 7 people)
Nasonex:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 3 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 66.0% - (4 of 6 people)

Most common drug interactions over time *:

< 1 month:
  • international normalised ratio increased
  • haematocrit decreased
  • haemoglobin decreased
  • platelet count decreased
  • urinary tract infection
  • haemorrhage
  • hereditary angioedema
  • international normalised ratio decreased
  • pancreatitis
  • respiratory distress
1 - 6 months:
  • asthma
  • alveolitis allergic
  • arthritis
  • blood glucose increased
  • blood lactate dehydrogenase increased
  • c-reactive protein increased
  • cardiac valve disease
  • dry mouth
  • ejection fraction decreased
  • fatigue
6 - 12 months:
  • sepsis
  • arthritis
  • asthma
  • blood glucose increased
  • blood lactate dehydrogenase increased
  • c-reactive protein increased
  • spinal compression fracture
  • white blood cell count increased
  • blister
  • chills
1 - 2 years:
  • visual disturbance
  • duodenal ulcer haemorrhage
2 - 5 years:
  • duodenal ulcer haemorrhage
5 - 10 years:
  • hunger
  • fatigue
  • kidney failure
  • loss of appetite
  • nausea
  • urine - abnormal color
10+ years:
  • haematocrit decreased
  • haematuria
  • international normalised ratio increased
  • rectal haemorrhage
not specified:
  • dizziness
  • nausea
  • dyspnoea
  • pain in extremity
  • pain
  • hypertension
  • anaemia
  • insomnia
  • fatigue
  • cough

Most common drug interactions by gender *:

female:
  • atrial fibrillation
  • dizziness
  • urinary tract infection
  • anxiety
  • pain
  • chest pain
  • nausea
  • asthenia
  • pain in extremity
  • weight decreased
male:
  • dyspnoea
  • dizziness
  • international normalised ratio increased
  • oedema peripheral
  • pain in extremity
  • dehydration
  • nausea
  • constipation
  • arthralgia
  • pyrexia

Most common drug interactions by age *:

20-29:
  • catheter related complication
  • deep vein thrombosis
  • diarrhoea haemorrhagic
  • nausea
30-39:
  • hypoxia
  • chest pain
  • deep vein thrombosis
  • dyspnoea
  • pulmonary embolism
  • tachycardia
  • wheezing
  • abdominal distension
  • abdominal pain upper
  • anaemia
40-49:
  • hereditary angioedema
  • pancreatitis
  • transaminases increased
  • urinary tract infection
  • anaemia
  • hepatic enzyme increased
  • angioedema
  • fatigue
  • anal cancer
  • aplasia pure red cell
50-59:
  • paraesthesia
  • hypertension
  • nasopharyngitis
  • pruritus
  • cerumen impaction
  • chest discomfort
  • ejection fraction decreased
  • hypotension
  • cough
  • dyspnoea
60+:
  • dizziness
  • atrial fibrillation
  • pain in extremity
  • asthenia
  • weight decreased
  • anxiety
  • nausea
  • fall
  • thrombocytopenia
  • herpes zoster

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Coumadin and Nasonex?

Can you answer these questions?

More questions for: Coumadin, Nasonex

You may be interested in these reviews

More reviews for: Coumadin, Nasonex

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.